Related Experiment Video
Updated: Jul 7, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
[Anti-apoptotic effect of the androgen receptor in human prostate cancer]
1Department of Urology, Shenzhen Sun Hospital of Dalian Medical University, Shenzhen, Guangdong 518000, China. shenfangyun@hotmail.com
Abstract:
Prostate cancer is one of the common cancers in old men. Androgen ablation is a major option for the treatment of the metastatic diseases. However, most of the cancers progress to a more aggressive stage, so-called androgen-independent (or hormone refractory) relapse beyond any cure. The androgen receptor (AR) is an important factor in regulating the differentiation and proliferation of prostate epithelial cells, and also plays a critical role in cellular survival. Studies have demonstrated that aberrant activation of the AR is a major determinant in prostate cancer progression. We have provide a brief summary of AR-mediated cellular survival and an introduction to the advances of RNA interference techniques in silencing AR expression as a novel therapy for prostate cancer.
Insights
Prostate cancer often becomes hormone-refractory, progressing despite androgen ablation. RNA interference offers a novel approach to silence androgen receptor (AR) expression, targeting cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Context:
- Prostate cancer is a prevalent malignancy in older men.
- Androgen ablation is a primary treatment for metastatic prostate cancer.
- Most treated cancers eventually develop resistance, becoming hormone-refractory.
Purpose:
- To summarize androgen receptor (AR)-mediated cellular survival mechanisms.
- To introduce RNA interference (RNAi) as a potential therapeutic strategy for prostate cancer.
Summary:
- The androgen receptor (AR) is crucial for prostate epithelial cell differentiation, proliferation, and survival.
- Aberrant AR activation drives prostate cancer progression and resistance to therapy.
- RNA interference (RNAi) techniques show promise for silencing AR expression and treating advanced prostate cancer.
Impact:
- Provides insights into AR signaling in prostate cancer progression.
- Highlights RNA interference as a novel therapeutic avenue for hormone-refractory prostate cancer.
- Facilitates further research into targeted AR-silencing therapies.
More Related Videos
09:59Quantitative Analysis of Autophagy using Advanced 3D Fluorescence Microscopy
Published on: May 3, 2013
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Apoptosis